CGT-2168: Phase III started

Cogentus began the double-blind, international Phase III COGENT-1 trial in 3,200 patients to evaluate aspirin plus CGT-2168 or Plavix clopidogrel from Bristol-Myers Squibb Co. (BMY, New York, N.Y.)....